MEDP Medpace Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MEDP

Price (delayed)

$181.94

Market cap

$5.65B

P/E Ratio

24.03

Dividend/share

N/A

EPS

$7.57

Enterprise value

$5.81B

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate ...

Highlights
The EPS is up by 50% YoY and by 11% QoQ
The net income has increased by 35% YoY and by 8% from the previous quarter
Medpace Holdings's quick ratio has shrunk by 70% YoY but it has increased by 2.9% QoQ
Medpace Holdings's equity has plunged by 59% YoY but it has increased by 10% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.medpace.com
Peers: OVID

Key stats

What are the main financial stats of MEDP
Market
Shares outstanding
31.05M
Market cap
$5.65B
Enterprise value
$5.81B
Valuations
Price to earnings (P/E)
24.03
Price to book (P/B)
14.64
Price to sales (P/S)
4.04
EV/EBIT
20.33
EV/EBITDA
17.82
EV/Sales
3.98
Earnings
Revenue
$1.46B
EBIT
$285.77M
EBITDA
$326.12M
Free cash flow
$351.17M
Per share
EPS
$7.57
Free cash flow per share
$10.84
Book value per share
$12.42
Revenue per share
$45.08
TBVPS
$20.13
Balance sheet
Total assets
$1.35B
Total liabilities
$966.11M
Debt
$188.87M
Equity
$386.39M
Working capital
-$469.51M
Liquidity
Debt to equity
0.49
Current ratio
0.42
Quick ratio
0.35
Net debt/EBITDA
0.49
Margins
EBITDA margin
22.3%
Gross margin
29.6%
Net margin
16.8%
Operating margin
19.1%
Efficiency
Return on assets
18.4%
Return on equity
60.4%
Return on invested capital
438.4%
Return on capital employed
52%
Return on sales
19.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MEDP stock price

How has the Medpace Holdings stock price performed over time
Intraday
0.79%
1 week
3.58%
1 month
-5.69%
1 year
13.35%
YTD
-14.34%
QTD
-14.34%

Financial performance

How have Medpace Holdings's revenue and profit performed over time
Revenue
$1.46B
Gross profit
$432.44M
Operating income
$278.7M
Net income
$245.37M
Gross margin
29.6%
Net margin
16.8%
The operating income has increased by 40% year-on-year and by 8% since the previous quarter
The net income has increased by 35% YoY and by 8% from the previous quarter
MEDP's gross profit is up by 32% year-on-year and by 7% since the previous quarter
MEDP's revenue is up by 28% year-on-year and by 6% since the previous quarter

Growth

What is Medpace Holdings's growth rate over time

Valuation

What is Medpace Holdings stock price valuation
P/E
24.03
P/B
14.64
P/S
4.04
EV/EBIT
20.33
EV/EBITDA
17.82
EV/Sales
3.98
The EPS is up by 50% YoY and by 11% QoQ
The P/E is 22% lower than the 5-year quarterly average of 30.8 and 9% lower than the last 4 quarters average of 26.3
MEDP's price to book (P/B) is 115% higher than its 5-year quarterly average of 6.8
Medpace Holdings's equity has plunged by 59% YoY but it has increased by 10% from the previous quarter
MEDP's revenue is up by 28% year-on-year and by 6% since the previous quarter
MEDP's price to sales (P/S) is 3.8% less than its last 4 quarters average of 4.2

Efficiency

How efficient is Medpace Holdings business performance
The company's return on equity has surged by 196% YoY and by 46% QoQ
MEDP's ROIC has soared by 60% YoY and by 31% QoQ
Medpace Holdings's return on assets has surged by 56% YoY and by 14% QoQ
The ROS is up by 11% YoY

Dividends

What is MEDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MEDP.

Financial health

How did Medpace Holdings financials performed over time
The company's total assets is 40% higher than its total liabilities
Medpace Holdings's quick ratio has shrunk by 70% YoY but it has increased by 2.9% QoQ
Medpace Holdings's current ratio has shrunk by 66% YoY but it has increased by 2.4% QoQ
The debt is 51% smaller than the equity
Medpace Holdings's equity has plunged by 59% YoY but it has increased by 10% from the previous quarter
The debt is up by 44% year-on-year but it is down by 32% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.